CDAX
2 007,20
|
0,28
|
0,01 %
|
Analysen zu CDAX-Werten
01.11.23 | BASF Overweight | JP Morgan Chase & Co. | |
31.10.23 | Knorr-Bremse Overweight | JP Morgan Chase & Co. | |
31.10.23 | Zalando Neutral | UBS AG | |
31.10.23 | FUCHS Add | Baader Bank | |
31.10.23 | Mercedes-Benz Group Kaufen | DZ BANK | |
31.10.23 | Symrise Add | Baader Bank | |
31.10.23 | Knorr-Bremse Hold | Jefferies & Company Inc. | |
31.10.23 | KION GROUP Buy | Warburg Research | |
31.10.23 | Knorr-Bremse Hold | Warburg Research | |
31.10.23 | BASF Hold | Warburg Research | |
31.10.23 | E.ON Buy | Deutsche Bank AG | |
31.10.23 | grenke Buy | Deutsche Bank AG | |
31.10.23 | BASF Market-Perform | Bernstein Research | |
31.10.23 | BASF Add | Baader Bank | |
31.10.23 | BASF Overweight | JP Morgan Chase & Co. | |
31.10.23 | BASF Sell | UBS AG | |
31.10.23 | WACKER CHEMIE Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
31.10.23 | EVOTEC Outperform | RBC Capital Markets | |
31.10.23 | Merck Overweight | JP Morgan Chase & Co. | |
31.10.23 | E.ON Buy | Goldman Sachs Group Inc. | |
31.10.23 | BASF Hold | Jefferies & Company Inc. | |
31.10.23 | Fresenius Medical Care Equal Weight | Barclays Capital | |
31.10.23 | Knorr-Bremse Buy | UBS AG | |
31.10.23 | E.ON Overweight | Barclays Capital | |
31.10.23 | Mercedes-Benz Group Outperform | RBC Capital Markets | |
31.10.23 | Knorr-Bremse Overweight | JP Morgan Chase & Co. | |
31.10.23 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
30.10.23 | E.ON Overweight | JP Morgan Chase & Co. | |
30.10.23 | MTU Aero Engines Equal Weight | Barclays Capital | |
30.10.23 | Gerresheimer Overweight | Barclays Capital | |
30.10.23 | Fresenius Overweight | Barclays Capital | |
30.10.23 | Zalando Underperform | Bernstein Research | |
30.10.23 | Bayer Neutral | JP Morgan Chase & Co. | |
30.10.23 | Nemetschek Hold | Deutsche Bank AG | |
30.10.23 | STRATEC Hold | Deutsche Bank AG | |
30.10.23 | STRATEC Hold | Deutsche Bank AG | |
30.10.23 | Nemetschek Add | Baader Bank | |
30.10.23 | Merck Overweight | Barclays Capital | |
30.10.23 | EVOTEC Buy | Warburg Research | |
30.10.23 | Bayer Overweight | Barclays Capital |